Shaifali Gupta M D Director Large Molecule Clinical Lab services will conduct a session on Bioanalysis Case Studies at APA India 2018 on 26th February 2018 Cliantha Research is a leading service provider for Biosimilar s clinical development Our diverse and expert team brings with it hands on experience in development including Regulatory support Medical Affairs and execution of Phase I IV studies across multiple geographies is recognized among the 5 for the conduct of Clinical Trials Globally by Global Data Report April 2017

Biomarker, Biosimilars, ClianthaResearch, Top, CROs, Biosimilar

Cliantha Research,  Biomarker, Biosimilars, ClianthaResearch, Top, CROs, Biosimilar

Shaifali Gupta (M.D.), Director - Large Molecule & Clinical Lab services will conduct a session on "#Biomarker Bioanalysis - Case Studies" at APA India 2018 on 26th February 2018.

Cliantha Research is a leading service provider for Biosimilar's clinical development. Our diverse and expert team brings with it, hands-on experience in #Biosimilars development including Regulatory support, Medical Affairs and execution of Phase I-IV studies across multiple geographies. #ClianthaResearch is recognized among the “#Top 5 #CROs for the conduct of #Biosimilar Clinical Trials Globally" by Global Data Report, April 2017.

Shaifali Gupta (M.D.), Director - Large Molecule & Clinical Lab services will conduct a session on "#Biomarker Bioanalysis - Case Studies" at APA India 2018 on 26th February 2018. Cliantha Research is a leading service provider for Biosimilar's clinical development. Our diverse and expert team brings with it, hands-on experience in #Biosimilars development including Regulatory support, Medical Affairs and execution of Phase I-IV studies across multiple geographies. #ClianthaResearch is recognized among the “#Top 5 #CROs for the conduct of #Biosimilar Clinical Trials Globally" by Global Data Report, April 2017.

Let's Connect

sm2p0